Crystal form of resmetirom, preparation method therefor, and use thereof
AssigneeCrystal Pharmaceutical (Suzhou) Co., Ltd.
InventorsMinhua CHEN, Chunxiang HUANG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new crystal form of Resmetirom (referred to as “Compound I”) and a preparation method therefor, a pharmaceutical composition comprising the crystal form, and a use of the crystal form in preparing a THR-β selective agonist drug and a drug for treating NASH and HeFH. Compared with the prior art, the provided crystal form of the compound I has one or more improved properties, solves problems existing in the prior art, and has a great value for the optimization and development of drugs containing the compound I.
Claims11
A crystalline form CSVI of Compound I, wherein the X-ray powder diffraction pattern comprises characteristic peaks at 2θ values of 9.6°±0.2°, 10.1°±0.2°, and 18.9°±0.2° using CuKα radiation,
Dependencies are inferred from the claim text.